1Beyersdorf F.The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage[J].Cardiovasc Res,2009,83(2):262-264.
2Coeytaux RR,Williams JM,Gray RN,et al.Percutaneous heart valve replacement for aortic stenosis:state of the evidence[J].Ann Intern Med,2010,153(5):314-316.
1Kato R.Foex P.Myocardial protection by anesthetic agents against ischemia-reperfusion injury:an update for anesthesiologists.Can J Anaesth,2002,49(8):777-791.
2Karck M,Ziemer G,Zoeller M,et al.Protection of the chronic hypoxie immature rat heart during global ischemia.Ann Thorac Surg,1995,59(3):699-706.
3Robinson LA,Brainbridge MV,Hearse DJ.Creatine phosphate:an additive myocardial protective and antiarrhythmic agent in cardiplegia.J Thorac Cardiovasc Surg,1984,87(2):190-200.
4Sales V A,Dzhaliashvili IV,Konorev EA.et al.Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine.Biokhimiia,1992,57(12):1763-1784.
5Hawkins RC,Tan HL.Comparison of the diagnostic utility of CK,CK-MB (activity and mass),troponin T and troponin I in patients with suspected acute myocardial infarction.Singapore Med J,1999,40(11):680-684.
6Collinson PO,Gaze DC,Stubbs PJ,et al.Diagnostic and prognostic role of cardiac troponin I (cTnl) measured on the DPC Immulite.CUn Biochem,2006,39(7):692-696.
7Konorev EA,Medvedeva NV,Jaliashvili IV,et al.Participation of calcium ions in the molecular mechanism of cardioprotective action of exogenous phosphocreatine.Basic Res Cardiol,1991,86(4):327-339.
8Sololl S,Conrad A,Eistert A,et al.Uptake of creatine phosphate into heart mitochondria:a leak in the creatine shuttle.Biochim Biophys Acta,1997,1320(1):27-33.
9Stoica SC.High-energy phosphates and the human donor heart.J Heart Lung Transplant,2004,23(9 Suppl):S244-S246.
10Perpech NB,Nedoshivim AO,Nesteroval IV.Neoton and thrombolytic therapy of myocardial infarction.Ter Arkh,2001,73(9):50-55.
